|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.00 USD | +1.16% |
|
+3.01% | -7.02% |
| Market Cap | 3.38B 2.96B 2.73B 2.56B 4.79B 319B 4.89B 32.81B 12.69B 157B 12.68B 12.4B 546B | P/E 2026 * |
249x | P/E 2027 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.11B 2.73B 2.52B 2.36B 4.42B 294B 4.51B 30.24B 11.7B 145B 11.69B 11.43B 503B | EV / Sales 2026 * |
6.26x | EV / Sales 2027 * | 4.33x |
| Free-Float |
98.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcutis Biotherapeutics, Inc.
| 1 day | +1.16% | ||
| 1 week | +3.01% | ||
| Current month | +25.82% | ||
| 1 month | +27.90% | ||
| 3 months | +20.64% | ||
| 6 months | -6.80% | ||
| Current year | -7.02% |
| 1 week | 26.18 |  | 28.38 |
| 1 month | 20.48 | | 28.38 |
| Current year | 19.3 | | 30.75 |
| 1 year | 13.06 | | 31.77 |
| 3 years | 1.76 | | 31.77 |
| 5 years | 1.76 | | 31.77 |
| 10 years | 1.76 | | 40.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 58 | 2017-03-31 |
| Corporate Officer/Principal | 71 | 2025-12-02 | |
Latha Vairavan
DFI | Director of Finance/CFO | - | 2025-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Heron
CHM | Chairman | 55 | 2019-11-30 |
Todd Watanabe
BRD | Director/Board Member | 58 | 2015-12-31 |
Howard Welgus
BRD | Director/Board Member | 74 | 2020-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Sell | Director | -635 | 0.0005% | ||
| 06-14 | Sell | Director | -4,946 | 0.0040% | ||
| 06-04 | Free | Director | 22,445 | 0.0179% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.16% | +3.01% | +87.50% | +215.97% | 3.38B | |
| +2.06% | +3.76% | +21.48% | -19.31% | 64.39B | |
| +0.74% | +3.52% | +53.14% | +219.37% | 56.12B | |
| -3.10% | +34.30% | +34.30% | +34.30% | 40.54B | |
| -2.36% | -1.25% | -52.13% | -58.98% | 37.98B | |
| +6.97% | +9.89% | +70.21% | -23.28% | 31.89B | |
| +12.59% | +5.18% | +144.26% | -44.13% | 26.69B | |
| +5.78% | +15.81% | +60.64% | +80.73% | 22.73B | |
| -1.25% | -1.31% | -4.39% | +142.42% | 16.66B | |
| -0.81% | +5.91% | +67.70% | +124.13% | 16.6B | |
| Average | +2.18% | +4.19% | +48.27% | +67.12% | 31.7B | |
| Weighted average by Cap. | +1.95% | +4.10% | +39.72% | +48.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 497M 436M 402M 376M 705M 46.89B 720M 4.83B 1.87B 23.18B 1.87B 1.83B 80.36B | 646M 566M 522M 489M 916M 60.92B 935M 6.27B 2.43B 30.11B 2.42B 2.37B 104B |
| Net income | 15.18M 13.31M 12.27M 11.48M 21.53M 1.43B 21.98M 147M 57.04M 708M 56.99M 55.74M 2.45B | 134M 118M 109M 102M 190M 12.66B 194M 1.3B 505M 6.26B 504M 493M 21.7B |
| Net Debt | -265M -232M -214M -200M -375M -24.96B -383M -2.57B -994M -12.33B -993M -972M -42.77B | -580M -508M -469M -439M -823M -54.7B -840M -5.63B -2.18B -27.03B -2.18B -2.13B -93.74B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | US$27.00 | +1.16% | 3,711,679 |
| 26-06-25 | US$26.69 | -2.48% | 1,971,901 |
| 26-06-24 | US$27.37 | +4.19% | 2,069,683 |
| 26-06-23 | US$26.27 | -1.46% | 1,664,015 |
| 26-06-22 | US$26.66 | +1.72% | 1,528,828 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARQT Stock
Select your edition
All financial news and data tailored to specific country editions
